State of Alaska Department of Revenue boosted its position in shares of Sotera Health (NYSE:SHC – Get Rating) by 1,529.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 153,284 shares of the company’s stock after acquiring an additional 143,877 shares during the period. State of Alaska Department of Revenue owned approximately 0.05% of Sotera Health worth $3,002,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in SHC. Principal Financial Group Inc. increased its stake in Sotera Health by 5.3% during the fourth quarter. Principal Financial Group Inc. now owns 10,750 shares of the company’s stock valued at $253,000 after acquiring an additional 541 shares during the period. Teacher Retirement System of Texas grew its stake in shares of Sotera Health by 20.0% in the 4th quarter. Teacher Retirement System of Texas now owns 16,416 shares of the company’s stock valued at $387,000 after purchasing an additional 2,739 shares during the period. Rhumbline Advisers grew its stake in shares of Sotera Health by 7.9% in the 4th quarter. Rhumbline Advisers now owns 89,395 shares of the company’s stock valued at $2,105,000 after purchasing an additional 6,525 shares during the period. Bank of Montreal Can bought a new stake in shares of Sotera Health in the 4th quarter valued at approximately $2,698,000. Finally, Ensign Peak Advisors Inc bought a new stake in shares of Sotera Health in the 4th quarter valued at approximately $122,000. 88.38% of the stock is currently owned by institutional investors.
Sotera Health Stock Up 1.2 %
NYSE:SHC opened at $7.41 on Friday. The stock’s fifty day moving average price is $17.33 and its two-hundred day moving average price is $19.53. Sotera Health has a 52-week low of $7.11 and a 52-week high of $27.38. The company has a debt-to-equity ratio of 2.83, a quick ratio of 2.53 and a current ratio of 2.81. The company has a market cap of $2.10 billion, a price-to-earnings ratio of 16.47 and a beta of 0.44.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on the company. The Goldman Sachs Group lowered Sotera Health from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $23.00 to $9.00 in a research note on Tuesday. JPMorgan Chase & Co. lowered Sotera Health from an “overweight” rating to an “underweight” rating and lowered their price objective for the company from $26.00 to $9.00 in a research note on Wednesday. TheStreet downgraded Sotera Health from a “c-” rating to a “d” rating in a report on Monday. Barclays reduced their target price on Sotera Health from $24.00 to $22.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 13th. Finally, Wolfe Research downgraded Sotera Health from an “outperform” rating to a “peer perform” rating and set a $26.00 target price on the stock. in a report on Thursday, June 9th. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Sotera Health currently has a consensus rating of “Hold” and a consensus target price of $20.86.
About Sotera Health
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.
- Get a free copy of the StockNews.com research report on Sotera Health (SHC)
- The Institutions Hold On To Darden Restaurants International
- What Steelcase’s Earnings Say About the Return to the Office?
- Is The Golden Age Of Homebuilding Already Over?
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.